Transplantation is the optimal treatment for patients with kidney failure, but rejection still causes premature graft loss in as many as 30 per cent of recipients. This project aims to cut the rejection rate by in half by using genomic technologies to improve the matching of donors and recipients, to monitor the immune response for rejection, and to develop personalized drug treatment regimes for each recipient. It offers the potential for $1 billion in healthcare savings over the next 15 years.

How are we going to positively impact transplant patients?

Tomorrow's Transplants

Transplant medicine is moving toward a future of precision medicine that will improve long-term patient outcomes. How success in transplant is defined in 2018 may look much different from what will define success in 2025.

50 Years of Transplant

October 24, 2018, marks 50 years since the first ever transplant in British Columbia.
Today thousands of British Columbians are alive because of an organ transplant.

Project Highlights

Our Goal

Partners

Team leaders

Activities

Publications

Research Team

Patient/Family Advisory

News & Events

Why GCTC?

The world of transplantation is changing at a breathtaking pace. We are committed to building a ground-breaking research team with a drive to translate research findings into clinical action, ultimately leading to continuous improvement for our patients in BC and beyond.

Our hope is to develop answers that holds the key to unleashing innovations across all areas of patient care, from increasing the supply of organs available for transplant, reducing organ rejection, improving immunosuppressive drugs, and monitoring health outcomes for transplant recipients.

Why GCTC?

The world of transplantation is changing at a breathtaking pace. We are committed to building a ground-breaking research team with a drive to translate research findings into clinical action, ultimately leading to continuous improvement for our patients in BC and beyond.

Our hope is to develop answers that holds the key to unleashing innovations across all areas of patient care, from increasing the supply of organs available for transplant, reducing organ rejection, improving immunosuppressive drugs, and monitoring health outcomes for transplant recipients.

Team leaders

Activities

Publications

Research Team

Patient/Family Advisory

News & Events

Project Highlights

Our Goal

Partners

Project Highlights

Project Leaders

  • Paul Keown (UBC)
  • Ruth Sapir-Pichhadze
    (McGill University)
  • Timothy Caulfield (University of Alberta)
  • Stirling Bryan (UBC)

Genome Centres

  • Genome British Columbia (administrative lead)
  • Génome Québec
  • Genome Alberta

Total Funding

  • $10.8 million
  • Total Funding In-kind contribution from private and industrial stakeholders 

Join the @GenomeCanadaTx conversation

Twitter feed is not available at the moment.

Latest Articles